Developers listed in the Medicare App Library will gain visibility to 68 million Medicare beneficiaries through the Medicare App and CMS discovery channels. The DiMe Seal evaluation is conducted ...

Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Click here to find out why HIMS is a Strong Buy.

Company Ready to Scale Growth through OneTest AI-Powered Blood Tests for Cancer and Longevity GAITHERSBURG, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market ...

Medicare Advantage plans had 35.5 million enrollees as of February 2026, up 3.2% from 34.4 million enrollees as of February 2025, according to data from the Centers for Medicare & Medicaid Services.

Traditional Medicare, also known as original Medicare, has historically required little in the way of pre-authorization for beneficiaries seeking services; pre-authorization was typically the domain ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. AARP offers savings & planning resources for all. Members also ...

Emanuel is vice provost for global initiatives and co-director of the Healthcare Transformation Institute at the Perelman School of Medicine and the Wharton School at the University of Pennsylvania.

Many retirees will see their prescription drug costs fall in 2026. However, Medicare Part B premiums and deductibles have increased. Many Medicare Advantage plan members could experience disruption ...

Health insurance stocks took a beating last week after the Trump Administration announced a near-freeze in government payments for Medicare Advantage plans. It’s an election year, politicians need ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump attends an event to promote ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations. The list includes Botox and the GLP-1 drug Trulicity. The negotiations stem from ...